Soliris is a medication used to treat rare and life-threatening conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Petitions related to Soliris focus on improving access to this costly medication for patients facing financial barriers. Issues highlighted in these petitions include the high cost of treatment, insurance coverage limitations, and the need for government intervention to make Soliris more affordable.
One petition with thousands of signatures calls for insurance companies to provide full coverage for Soliris, emphasizing the life-saving importance of this medication for patients with PNH and aHUS. Another petition urges pharmaceutical companies to reduce the price of Soliris to ensure equitable access for all who need it.
Join the movement to advocate for better access to Soliris and support patients in receiving the care they require. Your involvement can help bring attention to the challenges faced by individuals seeking treatment with Soliris and push for positive change in healthcare policies.
